Page 147 - Read Online
P. 147

Page 10 of 12                                                 Verolino et al. Vessel Plus 2018;2:17  I  http://dx.doi.org/10.20517/2574-1209.2018.32

                   2011;364:2187-98.
               9.   Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, Gleason TG, Buchbinder M, Hermiller J Jr, Kleiman NS,
                   Chetcuti S, Heiser J, Merhi W, Zorn G, Tadros P, Robinson N, Petrossian G, Hughes GC, Harrison JK, Conte J, Maini B, Mumtaz M,
                   Chenoweth S, Oh JK; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N
                   Engl J Med 2014;370:1790-8.
               10.  Otto C, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, Lee JC, Ruiz CE, Vassileva CM. 2017 ACC expert consensus
                   decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American
                   College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017;69:1313-46.
               11.  Kirtane AJ, Leon MB. The Placement of Aortic Transcatheter Valve (PARTNER) trial: clinical trials. Circulation 2012;125:3229-32.
               12.  Florath I, Albert A, Boening A, Ennker IC, Ennker J. Aortic valve replacement in octogenarians: identification of high-risk patients. Eur
                   J Cardiothorac Surg 2010;37:1304-10.
               13.  Dewey TM, Brown D, Ryan WH, Her- bert MA, Prince SL, Mack MJ. Reliability of risk algorithms in predicting early and late opera-
                   tive outcomes in high-risk patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg 2008;135:180-7.
               14.  Vahanian A, Alfieri OR, Al-Attar N, Antunes MJ, Bax J, Cormier B, Cribier A, De Jaegere P, Fournial G, Kappetein AP, Kovac J,
                   Ludgate S, Maisano F, Moat N, Mohr FW, Nataf P, Pierard L, Pomar JL, Schofer J, Tornos P, Tuzcu M, van Hout B, von Segesser LK,
                   Walther T. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of
                   Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of
                   Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2008;34:1-8.
               15.  Roques F, Nashef SA, Michel P; EuroSCORE study group. Risk factors for early mortality after valve surgery in Europe in the 1990s:
                   lessons from the EuroSCORE pilot program. J Heart Valve Dis 2001;10:572-7; discussion 577-8.
               16.  Ferguson TB Jr, Dziuban SW Jr, Edwards FH, Eiken MC, Shroyer AL, Pairolero PC, Anderson RP, Grover FL. The STS National Da-
                   tabase: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery,
                   The Society of Thoracic Surgeons. Ann Thoracic Surg 2000;69:680-91.
               17.  Green P, Woglom AE, Genereux P, Daneault B, Paradis JM, Schnell S, Hawkey M, Maurer MS, Kirtane AJ, Kodali S, Moses JW, Leon
                   MB, Smith CR, Williams M. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with se-
                   vere aortic stenosis: a single-center experience. JACC Cardiovasc Interv 2012;5:974-81.
               18.  Anand A, Harley C, Visvanathan A, Shah ASV, Cowell J, MacLullich A, Shenkin S, Mills NL. The relationship between preoperative
                   frailty and outcomes following transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Qual Care
                   Clin Outcomes 2017;3:123-32.
               19.  Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM
                   3rd, Thomas JD; ACC/AHA Task Force Members. 2014 AHA/ACC Guideline for the management of patients with valvular heart dis-
                   ease: executive summary; a report of the American College of Cardiology/American Heart Association Task Force on Practice Guide-
                   lines. Circulation 2014;129:e650.
               20.  Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block
                   PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PART-
                   NER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J
                   Med 2010;363:1597-607.
               21.  Shroyer AL, Coombs LP, Peterson ED, Eiken MC, DeLong ER, Chen A, Ferguson TB Jr, Grover FL, Edwards FH; Society of Thoracic
                   Surgeons. The Society of Thoracic Surgeons: 30-day operative mortality and morbidity risk models. Ann Thorac Surg 2003;75:1856-64.
               22.  Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH, Kodali SK,
                   Makkar RR, Fontana GP, Kapadia S, Bavaria J, Hahn RT, Thourani VH, Babaliaros V, Pichard A, Herrmann HC, Brown DL, Williams
                   M, Akin J, Davidson MJ, Svensson LG; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or
                   surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet
                   2015;385:2477-84.
               23.  Kapadia SR, Leon MB, Makkar RR, Tuzcu EM, Svensson LG, Kodali S, Webb JG, Mack MJ, Douglas PS, Thourani VH, Babaliaros
                   VC, Herrmann HC, Szeto WY, Pichard AD, Williams MR, Fontana GP, Miller DC, Anderson WN, Akin JJ, Davidson MJ, Smith CR;
                   PARTNER trial investigators. 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients
                   with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015;385:2485-91.
               24.  Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN,
                   Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of
                   transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2010;122:62-9.
               25.  Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler
                   O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ. Long-
                   term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. aortic valve im-
                   plantation (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8.
               26.  Brown DL. Expanding indications for TAVR: The preferred procedure in intermediate-risk patients? Cleve Clinic J Med 2017;84:e10-4.
               27.  Stähli BE, Tasnady H, Lüscher TF, Gebhard C, Mikulicic F, Erhart L, Bühler I, Landmesser U, Altwegg L, Wischnewsky MB, Grünen-
                   felder J, Falk V, Corti R, Maier W. Early and late mortality in patients undergoing transcatheter aortic valve implantation: comparison of
                   the Novel EuroSCORE II with Established Risk Scores. Cardiology 2013;126:15-23.
               28.  Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Craig Miller D, Herrmann HC,
   142   143   144   145   146   147   148   149   150   151   152